6
THE EPILEPSY REPORT OCTOBER 2008
7
THE EPILEPSY REPORT OCTOBER 2008
DC
epilepsy.
We have
also met other families who
have lost someone through epilepsy.
Their stories echo ours in terms of lack of
awareness about epilepsy- related deaths.
As a way of trying to go forwards after
this tragedy in our family and in trying
to help other families, we established a
memorial trust fund in Matt’s name. It is
a growth fund within Greater Good, The
Capital Region Community Foundation.
Each year the dividends are divided
equally between the ACT Epilepsy
Association and the Epilepsy Foundation
of Victoria to assist with research. It is
a small fund and it is our way of trying
to do something. But it is a drop in the
bucket – much more government and
community funding is needed to address
the impact of epilepsy on families and the
community.
Two years ago we had a fund raising
gig at the ANU bar to add to the money
in the memorial fund. A number of
Matt’s friends are very gifted musicians.
It was a fantastic night – it helped raise
awareness of epilepsy amongst the young
people there, it helped them do something
practical as a way of dealing with their
grief, and it did raise a lot of money.
Next month is the 5
th
anniversary of
Matt’s death. Two days ago was his
birthday –he would have been 31.
My hope is you can take away from
his story and from the other speakers,
a resolve to do what ever you can to
bring epilepsy out of the shadows to help
all the people who are struggling with
this condition. Epilepsy needs to have
a profile like cancer, diabetes, asthma,
and SIDS so that the wider community
is less ignorant and fearful of it. Funding
is also desperately needed for national
coordinated research into the extent of
the problem, diagnosis and treatment.
More funding is also needed for practical
support for people whose daily lives are
severely impacted by this condition –
transport, employment, finances, health
services and emotional support.
Matt’s story also touches on issues
about the health of men and young people
– how to encourage them to be better at
monitoring and managing their health
conditions and to be supported in this.
Thank you very much for your time and
for listening.
”
SUDEP is sudden unexpected death
in someone with epilepsy, who was
otherwise well, and in whom no other
cause of death can be found, despite
thorough post mortem examination and
blood tests. This does not include those
who die in status epilepticus and those
who die from a seizure-related accident.
In general, the risk of SUDEP for
an adult with epilepsy is low, at one in
3000 persons over a one-year period.
For persons with poorly controlled
seizures the risk is one in 100 persons
over one year. In children, SUDEP is
an even rarer occurrence with the risk
as low as one to two in 10, 000 over one
year.
To date we do not know what causes
SUDEP. Current research leads to
respiratory or cardiac dysfunction, but
the cause of this dysfunction still eludes
us and we cannot know who will be
affected.
However, over the years some
possible risk factors have been
suggested including:
Young adulthood
Early age of onset of seizures
Presence of Tonic clonic seizures
Increased frequency of seizures
Frequent changes of dose and type
of anitepileptic medication (AED)
Poor compliance with AEDs
Alcohol abuse
Certain epilepsy syndromes
Yet risk factors only tell part of the
story. Sometimes individuals with
infrequent seizures die, while others
with more frequent and apparently
more severe seizures do not.
People with epilepsy can take a very
positive approach to reducing risk by
making seizure freedom a high priority.
Good control of seizures is often
achieved quite simply by taking the
medication prescribed, at the correct
dose on a regular basis.
It is generally agreed that seizure
frequency is the factor most strongly
associated with an increased risk
of SUDEP, and that the ‘unknown’
category of seizure frequency, that
where seizure frequency is not known
or disclosed, showed the strongest
association with risk of SUDEP of all
seizure-frequency groups.
What is SUDEP?
When talking to bereaved families,
especially those whose children or
siblings were living independently when
they died from SUDEP, the question of
increased seizure frequency is one they
often can’t answer. They just don’t know.
Young adults however, often have
irregular lifestyles and overlook the
need to keep to a routine with their
medication. Sometimes they experience
side effects with the medication and
decide to stop taking it. In either case
seizures may occur or increase, but
they may choose to ignore this fearing
that disclosure may affect their ability
to retain a driving license, cause
problems with their employer, or
increase parental concern. They may
feel an occasional seizure is not too
serious and that they can manage this.
However, allowing seizures to occur
does put them at risk and it is incumbent
on us all to communicate to our young
adults the danger of hiding or ignoring
seizures, stopping or irregularly taking
medication, and that having ‘a life’
doesn’t have to mean an excessive
lifestyle. They need encouragement to
talk to a doctor with a listening ear, who
can work with them to plan a treatment
program which they accept, understand,
and follow.
Life is precious, and while the risk
of SUDEP is low, all factors that may
lead to injury or loss of life should
be included in any risk management
discussion. Informed decisions about
treatment and lifestyle can only be made
if all the information is provided and
consequences discussed.
Until research finds that elusive cause
for SUDEP, we can’t prevent it from
occurring, but we can try to minimize
the risk by seeking prompt medical
advice when a seizure occurs, taking
the medication as prescribed, and being
aware of lifestyle factors that can
provoke seizures and ways these factors
can be managed.
The above information was taken from Epilepsy
Australia’s publication Sudden Unexpected
Death in Epilepsy: a global conversation.
If you would like to find out more about SUDEP
the full text can be accessed online at
www.epilepsyaustralia.net.
T
he School of Clinical Medicine at
The Australian National University
in Canberra has highlighted epilepsy as
one of a number of chronic diseases that
deserve more attention in medical school
curricula.
There are relatively few people with
epilepsy in hospital wards these days,
which means that students may miss out
on valuable opportunities to learn first
hand about the disease and its impact on
people’s lives. Whilst medical training
placements have, in recent years,
extended into GP’s surgeries and other
community locations, the fact of the
matter is that most clinical training still
takes place in our busy hospitals. The
vast majority of people with epilepsy are
living independent lives well away from
the acute care setting where clinical
experiences and patients lives differ
enormously from the community setting.
Consequently, medical students may end
up with a rather limited and distorted
view of epilepsy as a clinical problem.
The ANU medical degree is a four-
year graduate program with around 90
students in each year group. Year 1 and
2 students spend one day each week
learning the art and science of clinical
medicine, including communication and
interviewing techniques and physical
Teaching medical students
about epilepsy
examination skills. An important part of
the curriculum involves the application
of these techniques and skills to the care
of people with chronic conditions such
as epilepsy.
The second semester program in Year
2 includes an ‘epilepsy day’ (usually
in September) where, with the support
of Epilepsy ACT, people from the
Canberra region who are living with
epilepsy volunteer to meet with small
groups of students to talk about their
conditions. These teaching sessions are
held in the very new and modern School
of Clinical Medicine at The Canberra
Hospital.
The sessions give students
the opportunity to practice their
interviewing skills and learn about
epilepsy and its effect on people’s lives.
People living with chronic conditions are
often the best people to teach students
in this sort of setting. Students also get
feedback on their knowledge and skills
from their colleagues and tutors, as well
as from the volunteers themselves. Each
session lasts 60-90 minutes.
Volunteers are often pleasantly
surprised by the experience of working
with medical students. Volunteer Helen,
37, found the atmosphere welcoming
and comfortable and was happy to
Dr Ashley Watson
ANU School of Clinical Medicine
participate. “The students are so curious
and ask any questions they can think of”
she said, “they are quite surprised how
symptoms vary and that the reality is
often different from the text book”.
Jacinta Cummins from Epilepsy ACT
said “this innovative approach broadens
the clinical experience of epilepsy for
students and Epilepsy ACT is delighted
to be of assistance with this program.”
From the volunteers perspective,
many learn new things about their
conditions. Some see the experience
as an opportunity to raise awareness
of their conditions in the healthcare
community. Some see the experience as
an opportunity to ‘give something back’
after all the care they have received.
Others just like spending time with
enthusiastic young people.
One thing is for certain: the students
and staff of the School of Clinical
Medicine greatly appreciate the
participation and contributions of
volunteers to the training of our future
doctors.
Interested people should contact
the ANU School of Clinical Medicine
for further information by emailing
irene.howgego@ anu.edu.au or call
02-62443630 or Epilepsy ACT on 02
6287 4555.
Volunteer Helen, being interviewed by students under supervision.